Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lind

Showing results (191-200 of 376) with videos related to

Pageof 38
Sort By:
Cytokine|November 5, 1997
CD19-selected B lymphocytes synthesize, secrete and migrate in the presence of IL-8. TNF-alpha and gammaIP-10 are also B lymphocyte migratory factorsL S Nielsen, J Frydenberg, M Lind, et al.
Journal of Long-Term Effects of Medical Implants|October 28, 1999
A review of ceramic coatings for implant fixationK Søballe, S Overgaard, E S Hansen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 27, 2000
A multicentre phase II pilot study of epirubicin and Taxol (paclitaxel) in patients with advanced breast cancerJ White, A Howells, A Jones, et al.
BMC Genomics|March 2, 2019
Comparing DNA methylation profiles in saliva and intestinal mucosaNerissa L Hearn, Aaron S Coleman, Vincent Ho, et al.
Scandinavian Journal of Medicine & Science in Sports|November 19, 2011
Mechanical stability of the femoral fixation for single- and double-bundle ACL reconstruction in an in vitro experimental modelM B Bohn, R Vestergaard, M Dalstra, et al.
Journal of Musculoskeletal & Neuronal Interactions|December 2, 2009
Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening modelR Aleksyniene, J S Thomsen, H Eckardt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
European Journal of Clinical Pharmacology|August 23, 1974
Steady-state plasma concentrations of alprenolol in manM D Rawlins, P Collste, M Frisk-Holmberg, et al.
The Journal of Bone and Joint Surgery. British Volume|September 29, 2005
Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion modelH Eckardt, M Ding, M Lind, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 1995
Chemotaxis of human osteoblasts. Effects of osteotropic growth factorsM Lind, B Deleuran, K Thestrup-Pedersen, et al.
Pageof 38

Showing results (191-200 of 376) with videos related to

Sort By:
Pageof 38
Cytokine|November 5, 1997
CD19-selected B lymphocytes synthesize, secrete and migrate in the presence of IL-8. TNF-alpha and gammaIP-10 are also B lymphocyte migratory factorsL S Nielsen, J Frydenberg, M Lind, et al.
Journal of Long-Term Effects of Medical Implants|October 28, 1999
A review of ceramic coatings for implant fixationK Søballe, S Overgaard, E S Hansen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 27, 2000
A multicentre phase II pilot study of epirubicin and Taxol (paclitaxel) in patients with advanced breast cancerJ White, A Howells, A Jones, et al.
BMC Genomics|March 2, 2019
Comparing DNA methylation profiles in saliva and intestinal mucosaNerissa L Hearn, Aaron S Coleman, Vincent Ho, et al.
Scandinavian Journal of Medicine & Science in Sports|November 19, 2011
Mechanical stability of the femoral fixation for single- and double-bundle ACL reconstruction in an in vitro experimental modelM B Bohn, R Vestergaard, M Dalstra, et al.
Journal of Musculoskeletal & Neuronal Interactions|December 2, 2009
Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening modelR Aleksyniene, J S Thomsen, H Eckardt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
European Journal of Clinical Pharmacology|August 23, 1974
Steady-state plasma concentrations of alprenolol in manM D Rawlins, P Collste, M Frisk-Holmberg, et al.
The Journal of Bone and Joint Surgery. British Volume|September 29, 2005
Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion modelH Eckardt, M Ding, M Lind, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 1, 1995
Chemotaxis of human osteoblasts. Effects of osteotropic growth factorsM Lind, B Deleuran, K Thestrup-Pedersen, et al.
Pageof 38